Niromed’s Post

𝐋𝐞𝐬𝐬 𝐭𝐡𝐚𝐧 𝐚 𝐰𝐞𝐞𝐤 𝐭𝐨 𝐠𝐨❗ There's still time to register for our highly-anticipated live session on #EUHTA. Paul and Graham will be guiding you from strategic planning to actionable steps, to ensure your readiness for Jan 2025! 🚀 ✅ 𝐒𝐢𝐠𝐧 𝐮𝐩 𝐡𝐞𝐫𝐞: https://lnkd.in/eJnrTeRH Have any questions? Pop them in the comments below and we'll address them during the session 🗨 #marketaccess #healthcare #pharmaceuticals #jca #jointclinicalassessment #healthtechnologyassessment #hta

Less than a week to go before our next webinar: EU HTA: moving from strategy to action for manufacturers

State Alert ❗ New Mexico has recently passed a drug price reporting bill set to take effect in 2025. 💊 Are you ready for the changes ahead? While there's still time to gather data, it's never too early to ensure your processes are in place for submitting annual reports and new drug reports. At G&M, we foresee this trend expanding to more states in the near future. Stay ahead of the curve and ensure compliance by preparing now. 📝 #CompliancePreparation #PharmaIndustry #GMHealth #ComplianceMatters #TrustedPartner #Pharmaceuticals

Q&C Services sees more Health Canada activity than anyone else in Canada due to the sheer number of products we import and the amount we consult with industry. The chart below shows the most frequently cited GMP sections in 2023.   Read the Q&C Services’ full 2023 analysis of Health Canada GMP Drug Inspection in the QuicknoteTM : https://lnkd.in/e-y439zR   See how Q&C services can help improve your processes. https://lnkd.in/gjtUuXi      #gmp, #pharmaceuticals, #qualityassurance, #consulting

How will the Inflation Reduction Act impact #pharmaceuticals? From drug development challenges to pricing strategies, get expert insights on the future of healthcare policy and pricing. Learn from industry leaders about CMS pricing negotiations and adapting to regulatory shifts. In this webinar, you’ll learn: • Strategies to navigate IRA's challenges • Insights on value-based pricing • Ways to prepare for regulatory changes Register to watch now: https://ow.ly/7vh650QlwPG

Looking for ways to impact patient outcomes through an improved clinical supply chain process? Check out the recent Loftware report to learn how adopting agility in your clinical supply chain can ensure safety, traceability, and regulatory compliance: https://lnkd.in/eruJavHG #clinicaltrials #pharma #healthcare #pharmaceuticals 

With a projected growth of USD 18.4 billion from 2022 to 2027, it's an exciting time for the industry. Legislative changes supporting pharma growth are paving the way for increased demand in pharmaceutical production and consumption. Coolsmart is at the forefront of this growth, ensuring efficient transportation and warehousing services. Learn more about the booming market dynamics. http://bit.ly/48TQ6HF #Coolsmart #MedicalLogistics #Healthcare #CourierServices #Medical #SupplyChain #MedicalLogisticsSolutions #ClinicalLaboratories #MedicalSupplyChain #Hospitals #Pharmaceuticals #HealthcareLogistics #PharmaGrowth

💊 Just before the end of 2023, Reuters published an article breaking a story from data analyzed by 3 Axis Advisors, a healthcare research firm. The analysis evaluated anticipated drug price hikes in the coming month, revealing that approximately 500 drugs of varying doses and formulations from over 140 brands are expected to increase their list prices in January 2023. For example, Pfizer is projected to have the most significant number of January drug price increases, accounting for 25% of the anticipated increases. Overall, Pfizer intends to increase the cost of 124 drugs and 22 additional drugs through Hospira.🌐💡 #HealthcareNews #DrugCosts #MedicalUpdates #PrescriptionPrices #HealthAlert #StayInformed #Pharmaceuticals #DrugPricesRise #HealthcareCosts #MedicalInsights #HealthcareChanges #DrugIndustry #PatientCare #HealthcareAwareness #PrescriptionMedication #HealthcareCommunity #MedicalCosts #WellnessJourney #HealthcareNow #DrugAffordability #HealthcareImpact #MedicalNews #HealthcareUpdates #PrescriptionDrugs #DrugMarket #CostOfMedicine #PharmaIndustry

Decision-making by drug regulators and HTA institutions takes place under uncertainty caused by data gaps. Uncertainty has a major impact on value perception and pricing. This newsletter deals with uncertainties of the authorities and how drug manufacturers should deal with it for optimal pricing. #pharmaceuticals #cellandgenetherapies #decisionmaking #marketaccess #uncertainty #marketingapproval #HTA #value #pricingstrategy #managedentryagreements

Speed and efficiency in product registration are imperative. We're bringing vital healthcare solutions to market—and that requires acceleration. With Niromed's fast track registration process, your products can swiftly gain approval and enter the market, ensuring a competitive edge. ⚡ Combining fine-tuned processes and adaptability, our seasoned professionals navigate the complexities of regulatory frameworks with precision. Reach out to discover how Niromed's fast track registration can accelerate your product's journey to market, enhancing efficiency and competitiveness. #productregistration #pharmaceutical #pharmacy #fasttrack